Lymphocyte activation gene (LAG)-3 is a potential immunotherapeutic target for microsatellite stable, programmed death-ligand 1 (PD-L1)-positive endometrioid endometrial cancer
Jin Hwa Hong(Korea University Medical Center), Yikyeong Chun(Korea University Medical Center), Yung‐Taek Ouh(Ansan University), Hyun‐Woong Cho(Korea University Medical Center), Jae Kwan Lee(Korea University)
Cited by 23
Related Papers
Methionine consumption by cancer cells drives a progressive upregulation of PD-1 expression in CD4 T cells
|Nature Communications|2023|71
Interleukin-6 expression by interactions between gynecologic cancer cells and human mesenchymal stem cells promotes epithelial-mesenchymal transition
|International Journal of Oncology|2015|63
Preeclampsia: A risk factor for gestational diabetes mellitus in subsequent pregnancy
|PLoS ONE|2017|57
Prevalence of human papillomavirus genotypes and precancerous cervical lesions in a screening population in the Republic of Korea, 2014–2016
|Journal of Gynecologic Oncology|2017|53
Risk factors for type-specific persistence of high-risk human papillomavirus and residual/recurrent cervical intraepithelial neoplasia after surgical treatment
|Obstetrics & Gynecology Science|2020|51